Beam Therapeutics Inc. BEAM
25.27 USD -2.52 (-9.08%)
Nov 5, 2026, 1:14 PM EST
24.88 Day range 27.48
20.23 52-week range 38.26
- YTD
- -8.85%
- 1 year
- +9.52%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 139.74M | 63.52M | 377.71M | 60.92M | 51.84M | |
| 139.74M | 63.52M | 377.71M | 60.92M | 51.84M | |
| -383.69M | -415.57M | -176.49M | -338.48M | -392.46M | |
| -79.99M | -376.74M | -132.53M | -289.09M | -370.64M | |
| -0.81 | -4.58 | -1.72 | -4.13 | -5.77 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 301.62M | 290.11M | 444.61M | 245.52M | 572.74M | |
| 1.48B | 1.10B | 1.46B | 1.34B | 1.47B | |
| 242.82M | 370.28M | 478.38M | 608.24M | 647.72M | |
| 154.12M | 161.43M | 172.69M | 179.00M | 147.64M | |
| 1.24B | 733.54M | 981.33M | 733.47M | 826.74M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -345.10M | -347.25M | -149.19M | 22.53M | -66.27M | |
| -121.44M | 185.01M | 71.84M | -461.34M | -294.14M | |
| 478.05M | 7.74M | 276.45M | 111.59M | 756.14M | |
| -14.95M | -8.95M | -33.73M | -48.95M | -46.81M | |
| 11.51M | -154.50M | 199.09M | -327.22M | 395.73M |